Vimarsana
Biggest News Aggregation in the World

Adel Aref News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adel Aref. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adel Aref Today - Breaking & Trending Today

Djokovic says Australian Open deportation drama paved w... - Vimarsana News

Djokovic says Australian Open deportation drama paved w...

The 35-year-old Serb says he felt like ‘the villain of the world’ when he was deported from Australia because of his anti-vaccination stance. But he says the time off the circuit renewed his determination, and he is back in the country to win.

Naomi Osaka's Australian Open status remains unclear as 2023 tournament nears - Vimarsana News

Naomi Osaka's Australian Open status remains unclear as 2023 tournament nears

The last time Osaka was seen on the court was during the Pan Pacific Open in Tokyo in September 2022

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair - Vimarsana News

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

A new class of glioma drugs exploits tumors that lack the DNA repair enzyme MGMT; the drugs lead to the generation of cytotoxic DNA and selectively kill tumor cells without the risk of resistance, researchers report.

Science News | Research Reveals Glioma Drug Exploits DNA Repair Defects to Selectively Target Drug-resistant Tumors - Vimarsana News

Science News | Research Reveals Glioma Drug Exploits DNA Repair Defects to Selectively Target Drug-resistant Tumors

Get latest articles and stories on Science at LatestLY. A new class of glioma medications takes advantage of tumours lacking the DNA repair enzyme MGMT; the medications cause the generation of cytotoxic DNA and kill tumour cells specifically without the risk of developing resistance, according to research. Science News | Research Reveals Glioma Drug Exploits DNA Repair Defects to Selectively Target Drug-resistant Tumors.